SCHEMBL574115

SCHEMBL574115

Cc1cn(-c2cc(NC(N)=O)cc(C(F)(F)F)c2)cn1

nearest known ligand 0.80

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
NR2E1 Q9Y466 20/20 0.80

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1927257 0.90 NR2E1 (0.84) NR2E1
SCHEMBL13261062 0.89 NR2E1 (1.00) NR2E1
SCHEMBL12516822 0.86 NR2E1 (0.77) NR2E1
SCHEMBL31014309 0.85 NR2E1 (0.75) NR2E1
SCHEMBL12354400 0.84 NR2E1 (0.73) NR2E1
SCHEMBL20503056 0.83 NR2E1 (0.84) NR2E1
SCHEMBL29561954 0.83 NR2E1 (1.00) NR2E1
SCHEMBL31729797 0.82 NR2E1 (0.82) NR2E1
SCHEMBL15189550 0.82 NR2E1 (0.70) NR2E1
SCHEMBL4254143 0.81 NR2E1 (0.71) NR2E1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3191449-A1 NOVEL COMPOUNDS AS REARRANGED DURING TRANSFECTION (RET) INHIBITORS GlaxoSmithKline Intellectual Property Development Limited (GB) 2017-07-19 EP disclosed
WO-2016037578-A1 NOVEL COMPOUNDS AS REARRANGED DURING TRANSFECTION (RET) INHIBITORS GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2016-03-17 WO disclosed